1. AB0001 Still's Disease – Similar Gene Expression Profiles Demonstrate Presence of an IL-1 Response Signature in SJIA and AOSD. (9th June 2015) Authors: Brachat, A.; Feist, E.; Behrens, F.; Blank, N.; Nanguneri, N.; Specker, C.; Witt, M.; Zernicke, J.; Martini, A.; Junge, G. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 891 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
2. AB0926 Long-Term Safety and Maintenance of Efficacy of Canakinumab Liquid Formulation in Acute Gouty Arthritis Patients: Results From a 36 Week Extension Study. (9th June 2015) Authors: Möricke, R.; Sunkureddi, P.; Toth, E.; Brown, J.P.; Machein, U.; Lheritier, K.; Junge, G.; Kivitz, A. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 1209 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
3. Everolimus is associated with a reduced incidence of cytomegalovirus infection following de novo cardiac transplantation. Issue 2 (26th September 2012) Authors: Kobashigawa, J.; Ross, H.; Bara, C.; Delgado, J.F.; Dengler, T.; Lehmkuhl, H.B.; Wang, S.‐S.; Dong, G.; Witte, S.; Junge, G.; Potena, L. Journal: Transplant infectious disease Issue: Volume 15:Issue 2(2013) Page Start: 150 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
4. FRI0330 Safety and Efficacy of Canakinumab in Frequently Flaring Gouty Arthritis Patients Who are Contraindicated, Intolerant or Unresponsive to Non-Steroidal Anti- Inflammatory Drugs and/or Colchicine: Results from 3 Years Follow-Up. (9th June 2015) Authors: Alten, R.; Bardin, T.; Bloch, M.; Lheritier, K.; Machein, U.; Junge, G.; So, A.; Schlesinger, N. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 544 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
5. FRI0488 A Phase Iii Pivotal Umbrella Trial of Canakinumab in Patients with Autoinflammatory Periodic Fever Syndromes (Colchicine Resistant FMF, HIDS/MKD and TRAPS). (15th July 2016) Authors: De Benedetti, F.; Anton, J.; Gattorno, M.; Lachmann, H.; Kone-Paut, I.; Ozen, S.; Frenkel, J.; Simon, A.; Zeft, A.; Ben-Chetrit, E.; Hoffman, H.; Joubert, Y.; Lheritier, K.; Speziale, A.; Junge, G. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 615 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
6. FRI0489 Canakinumab Improves Patient Reported Outcomes in Patients with Periodic Fever Syndromes. (15th July 2016) Authors: Lachmann, H.; Simon, A.; Anton, J.; Gattorno, M.; Kone-Paut, I.; Ozen, S.; Frenkel, J.; Ben-Chetrit, E.; Hoffman, H.; Zeft, A.; Joubert, Y.; Lheritier, K.; Speziale, A.; Junge, G.; Gregson, J.; De Benedetti, F. Journal: Annals of the rheumatic diseases Issue: Volume 75(2016)Supplement 2 Page Start: 616 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
7. OP0302 IANALUMAB (VAY736), A DUAL MODE OF ACTION BIOLOGIC COMBINING BAFF RECEPTOR INHIBITION WITH B CELL DEPLETION, REACHES PRIMARY ENDPOINT FOR TREATMENT OF PRIMARY SJOGREN'S SYNDROME. (2nd June 2020) Authors: Dörner, T.; Bowman, S. J.; Fox, R.; Mariette, X.; Papas, A.; Grader-Beck, T.; Fisher, B. A.; Barcelos, F.; De Vita, S.; Schulze-Koops, H.; Moots, R. J.; Junge, G.; Woznicki, J.; Sopala, M.; Luo, W. L.; Hueber, W. Journal: Annals of the rheumatic diseases Issue: Volume 79(2020)Supplement 1 Page Start: 187 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
8. Renal Function at Two Years in Liver Transplant Patients Receiving Everolimus: Results of a Randomized, Multicenter Study. Issue 7 (28th May 2013) Authors: Saliba, F.; De Simone, P.; Nevens, F.; De Carlis, L.; Metselaar, H. J.; Beckebaum, S.; Jonas, S.; Sudan, D.; Fischer, L.; Duvoux, C.; Chavin, K. D.; Koneru, B.; Huang, M. A.; Chapman, W. C.; Foltys, D.; Dong, G.; Lopez, P. M.; Fung, J.; Junge, G. Journal: American journal of transplantation Issue: Volume 13:Issue 7(2013) Page Start: 1734 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
9. SAT0522 Canakinumab Pharmacokinetics in Patients Younger Than 2 Years Old with Cryopyrin Associated Periodic Syndromes. (9th June 2015) Authors: Kalabus, J.; Uziel, Y.; Brogan, P.; Hofer, M.; Kuemmerle-Deschner, J.; Lauwerys, B.; Speziale, A.; Laxer, R.; Lachmann, H.; Sun, H.; Abrams, K.; Leon, K.; Junge, G. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 849 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗
10. SAT0532 Efficacy and Safety of Canakinumab in Patients with Active Recurrent or Chronic TNF-Receptor Associated Periodic Syndrome (TRAPS). (9th June 2015) Authors: Lachmann, H.; Cattalini, M.; Obici, L.; Barcellona, R.; Speziale, A.; Joubert, Y.; Junge, G.; Gattorno, M. Journal: Annals of the rheumatic diseases Issue: Volume 74(2015)Supplement 2 Page Start: 852 Record Type: Journal Article View Content: Available online (eLD content is only available in our Reading Rooms) ↗